NCI677397 targeting USP24 ‐mediated induction of lipid peroxidation induces ferroptosis in drug‐resistant cancer cells
Molecular Oncology · 2023
DOI: 10.1002/1878-0261.13574 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Oncology, 2023. Verfasst von Shao-An Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Respiratory Therapy, College of Medicine, Taipei Medical University, Taiwan. Hauptthemen laut MEDLINE: Ferroptosis, Drug Resistance, Neoplasm, Lipid Peroxidation, Ubiquitin Thiolesterase. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Technology, Taiwan, National Science and Technology Council.
Abstract (Originalsprache)
Cancer represents a profound challenge to healthcare systems and individuals worldwide. The development of multiple drug resistance is a major problem in cancer therapy and can result in progression of the disease. In our previous studies, we developed small‐molecule inhibitors targeting ubiquitin‐specific peptidase 24 (USP24) to combat drug‐resistant lung cancer. Recently, we found that the USP24 inhibitor NCI677397 induced ferroptosis, a type of programmed cell death, in drug‐resistant cancer cells by increasing lipid reactive oxygen species (ROS) levels. In the present study, we investigated the molecular mechanisms and found that the targeting of USP24 by NCI677397 increased gene expression of most lipogenesis‐related genes, such as acyl‐CoA synthetase long‐chain family member 4 ( ACSL4 ), and activated autophagy. In addition, the activity of several antioxidant enzymes, such as glutathione peroxidase 4 (GPX4) and dihydrofolate reductase (DHFR), was inhibited by NCI677397 treatment via an increase in protein degradation, thereby inducing lipid ROS production and lipid peroxidation. In summary, we demonstrated that NCI677397 induced a marked increase in lipid ROS levels, subsequently causing lipid peroxidation and leading to the ferroptotic death of drug‐resistant cancer cells. Our study provides new insights into the clinical use of USP24 inhibitors as ferroptosis inducers (FINs) to block drug resistance during chemotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Respiratory Therapy, College of Medicine, Taipei Medical University, Taiwan.
- Cardiovascular Research Institute, University of California, San Francisco, CA, USA.
- Department of Biotechnology and Bioindustry Sciences, National Cheng Kung University, Tainan, Taiwan.
ORCID-Profile: Jan-Jong Hung
Förderung
- Ministry of Science and Technology, Taiwan
- National Science and Technology Council
Zitieren
APA
Wang, S. A., Wu, Y. C., Yang, F. M., Hsu, F. L., Zhang, K., & Hung, J. J. (2023). NCI677397 targeting USP24 ‐mediated induction of lipid peroxidation induces ferroptosis in drug‐resistant cancer cells. Molecular Oncology. https://doi.org/10.1002/1878-0261.13574
Vancouver
Wang SA, Wu YC, Yang FM, Hsu FL, Zhang K, Hung JJ. NCI677397 targeting USP24 ‐mediated induction of lipid peroxidation induces ferroptosis in drug‐resistant cancer cells. Molecular Oncology. 2023. doi:10.1002/1878-0261.13574
BibTeX
@article{Wang2023,
author = {Wang, Shao-An and Wu, Yu-Chih and Yang, Feng-Ming and Hsu, Feng-Lin and Zhang, Kuan and Hung, Jan-Jong},
title = {NCI677397 targeting USP24 ‐mediated induction of lipid peroxidation induces ferroptosis in drug‐resistant cancer cells},
journal = {Molecular Oncology},
year = {2023},
doi = {10.1002/1878-0261.13574}
}
EUVIMED